Iron Toxicity

← Back to Index (πŸš‘ Emergencies and Critical Care)

Etiology and Pathophysiology

Iron Preparation Percentage of Elemental Iron
Ferrous sulfate 20%
Ferrous gluconate 12%
Ferrous fumarate 33%

Clinical Manifestations

Phase Time After Ingestion Characteristic Clinical Features
1. Gastrointestinal 6 hours Vomiting, diarrhea, hematemesis, hematochezia.
2. Latent 6βˆ’24 hours Resolution of gastrointestinal symptoms, tachycardia, acidosis, depressed mental status.
3. Systemic 12βˆ’24 hours Return of gastrointestinal symptoms, severe acidosis, leukocytosis, coagulopathy, renal failure, lethargy or coma, and cardiovascular collapse.
4. Hepatic 2βˆ’5 days Fulminant liver failure, coagulopathy.
5. Obstructive 3βˆ’6 weeks Pyloric or bowel scarring leading to obstruction.

Diagnostic and Laboratory Evaluation

Emergency Management

Gastrointestinal Decontamination

Antidotal Therapy

Antidote Parameter Guidelines for Deferoxamine Administration
Indications Serum iron concentration >500 ΞΌg/dL OR the presence of moderate to severe symptoms (e.g., metabolic acidosis, lethargy) regardless of the serum iron level.
Dosage Continuous intravenous infusion initiated at 15 mg/kg/hr (maximum dose: 6 g/24 hr).
Adverse Effects Hypotension (which can be mitigated by titrating the dose up slowly).
Complications of Prolonged Use Infusions lasting >24 hours are associated with acute respiratory distress syndrome (ARDS) and Yersinia sepsis.